152 related articles for article (PubMed ID: 38150048)
41. Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation.
Rapetti-Mauss R; Bustos V; Thomas W; McBryan J; Harvey H; Lajczak N; Madden SF; Pellissier B; Borgese F; Soriani O; Harvey BJ
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4159-4164. PubMed ID: 28373572
[TBL] [Abstract][Full Text] [Related]
42. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
[TBL] [Abstract][Full Text] [Related]
43. Circulating microRNA-762 upregulation in colorectal cancer may be accompanied by Wnt-1/β-catenin signaling.
Lai PS; Chang WM; Chen YY; Lin YF; Liao HF; Chen CY
Cancer Biomark; 2021; 32(2):111-122. PubMed ID: 34092606
[TBL] [Abstract][Full Text] [Related]
44. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
[TBL] [Abstract][Full Text] [Related]
45. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
46. β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers.
Kim WK; Kwon Y; Jang M; Park M; Kim J; Cho S; Jang DG; Lee WB; Jung SH; Choi HJ; Min BS; Il Kim T; Hong SP; Paik YK; Kim H
Sci Rep; 2019 Dec; 9(1):18440. PubMed ID: 31804558
[TBL] [Abstract][Full Text] [Related]
47. Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.
Guo YH; Wang LQ; Li B; Xu H; Yang JH; Zheng LS; Yu P; Zhou AD; Zhang Y; Xie SJ; Liang ZR; Zhang CM; Zhou H; Qu LH
Oncotarget; 2016 Jul; 7(27):42513-42526. PubMed ID: 27285761
[TBL] [Abstract][Full Text] [Related]
48. CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway.
Li X; Hu W; Zhou J; Huang Y; Peng J; Yuan Y; Yu J; Zheng S
Cell Commun Signal; 2017 Oct; 15(1):38. PubMed ID: 28974231
[TBL] [Abstract][Full Text] [Related]
49. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
[TBL] [Abstract][Full Text] [Related]
50. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
51. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
52. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
53. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
[TBL] [Abstract][Full Text] [Related]
54. Silencing of CEMIP suppresses Wnt/β-catenin/Snail signaling transduction and inhibits EMT program of colorectal cancer cells.
Liang G; Fang X; Yang Y; Song Y
Acta Histochem; 2018 Jan; 120(1):56-63. PubMed ID: 29173982
[TBL] [Abstract][Full Text] [Related]
55. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway.
Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L
Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031
[TBL] [Abstract][Full Text] [Related]
56. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Wang P; Gao XY; Yang SQ; Sun ZX; Dian LL; Qasim M; Phyo AT; Liang ZS; Sun YF
Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920
[TBL] [Abstract][Full Text] [Related]
57. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
[TBL] [Abstract][Full Text] [Related]
58. β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition.
Song Q; Han Z; Wu X; Wang Y; Zhou L; Yang L; Liu N; Sui H; Cai J; Ji Q; Li Q
Front Cell Dev Biol; 2021; 9():650067. PubMed ID: 33996812
[TBL] [Abstract][Full Text] [Related]
59. Ursolic Acid Suppresses Colorectal Cancer by Down-Regulation of Wnt/β-Catenin Signaling Pathway Activity.
Zhao H; Tang S; Tao Q; Ming T; Lei J; Liang Y; Peng Y; Wang M; Liu M; Yang H; Ren S; Xu H
J Agric Food Chem; 2023 Mar; 71(9):3981-3993. PubMed ID: 36826439
[TBL] [Abstract][Full Text] [Related]
60. MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.
Xiao Q; Gan Y; Li Y; Fan L; Liu J; Lu P; Liu J; Chen A; Shu G; Yin G
Oncogene; 2021 May; 40(19):3364-3377. PubMed ID: 33863999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
